Children aged between six and seventeen are going to be tested for Oxford/AstraZeneca vaccine efficacy, The Guardian reported, in a new clinical trial beginning this month with 300 volunteers.
According to the Royal College of Paediatrics and Child Health, it is rare for Covid-19 to cause death and severe illness to children.
“In children, the evidence is now clear that Covid-19 is associated with a considerably lower burden of morbidity and mortality compared to that seen in the elderly,” it said.
Andrew Pollard, chief investigator on the Oxford vaccine trial, said: “While most children are relatively unaffected by coronavirus and are unlikely to become unwell with the infection, it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination. These new trials will extend our understanding of control of Sars-CoV2 to younger age groups.”